COMPARE · Reviewed August 3, 2026
ALHC vs UNH
Verdict: Side-by-side breakdown using the Bull Rankings model. ALHC scored 58.9, UNH scored 61.8 — UNH leads.
Compare another set
Different reporting periods. ALHC's fundamentals are as of June 2026, but UNH's are as of March 2026 — a 3-month gap. Growth, margin and valuation figures below therefore describe different windows and aren't strictly like-for-like.
ALHC
Alignment Healthcare, Inc.
58.9
$13.76 · $2.9B
fundamentals as of
Score gap
2.9
UNH leads
UNH
UnitedHealth Group Incorporated
61.8
$410.32 · $372.6B
fundamentals as of
The model, pillar by pillar (0–100 each)
ALHC
stronger →← stronger
UNH
46
Qualityreturns · margins · balance sheet
59
100
Growthrevenue & earnings expansion
87
45
Valuevaluation vs sector peers
46
UNH is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
ALHC
UNH
$178mC
FCF
$19.7bA-
+46.1%A
Rev
+11.8%B
1.25C
D/E
0.69C+
72.4xD
P/E
30.9xB
1.66C+
PEG
1.28B
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
ALHC
UNH
24% below
Price vs fair valuelower is cheaper
27% below
~8%/yr
Growth the price implies10-yr FCF · lower = less priced in
~1%/yr
+1%
1-yr DCF upside
+20%
+32%
5-yr DCF upside
+37%
+96%
10-yr DCF upside
+68%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
ALHC
Why this score
- Diluting shareholders
UNH
Why this score
- Raising its dividend
The companies
ALHCAlignment Healthcare, Inc.
Why now
Healthcare Plans · market cap $2.9b. Down 45% from 52-week high of $25.12 — deep drawdown territory. Revenue growing +46% — in hypergrowth territory. 13 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $24.62 (implying +79% upside).
Moat
ROE 20% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Trailing P/E 72.4x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Down 45% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Net margin 0.9% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
UNHUnitedHealth Group Incorporated
Why now
Healthcare Plans · market cap $372.6b. 11% off the 52-week high of $461.62. Revenue growing +12%, comfortably above the S&P median. 26 sell-side analysts rate this a Buy with a mean 1-yr target of $475.23 (implying +16% upside).
Moat
ROE 14% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. FCF converts 139% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined. $372.6b market cap places it among the largest companies in the sector — distribution, R&D, and customer-acquisition costs amortize across a base peers can't replicate.
Risk
Trailing P/E 31x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. Net margin 3.1% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.